OVERVIEW

Amid the coronavirus pandemic, the market size for precision medicine software is expected to grow at a CAGR of 12.3% during the forecast period. Factors such as increasing government funding for precision medicine programs, increasing COVID-19 cases, collaborations between pharmaceutical and software companies, and growth in the number of patients with cancer are driving growth in the software market for precision medicine. The report discusses in detail the impact of COVID-19 on market for the year 2020 and beyond.

TABLE OF CONTENT

1 Global Precision Medicine Software Market

• 1.1 Study Objectives
• 1.2 Market Definition
• 1.3 Study Scope
  • 1.3.1 Markets Covered
  • 1.3.2 Geographic Scope

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Precision Medicine Software Market – Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Precision Medicine Software Market – Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Precision Medicine Software Market – Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis – Top 10 companies

• 6 Global Precision Medicine Software Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Precision Medicine Software Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Precision Medicine Software Market – By Delivery Mode (Market Size – &

million/billion)

• • 8.1 On-premise Delivery Mode
  • 8.2 Cloud-based Delivery Mode

• 9 Global Precision Medicine Software Market - By Application
  • 9.1 Oncology
  • 9.2 Pharmacogenomics
  • 9.3 Rare Diseases
  • 9.4 Other

• 10 Global Precision Medicine Software Market - By End-User
  • 10.1 Healthcare Providers
  • 10.2 Research Centers and Academic Institutes
  • 10.3 Pharmaceutical and Biotechnology Companies
  • 10.4 Other

• 11 Global Precision Medicine Software Market – By Geography (Market Size – &

million/billion)

• • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 U.K
    • 11.3.2 Germany
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Rest of APAC
  • 11.5 Rest of the World
    • 11.5.1 South America
    • 11.5.2 Middle East
    • 11.5.3 Africa

• 12 Global Precision Medicine Software Market – Entropy
  • 12.1 New product launches
  • 12.2 M&A's, collaborations, JVs and partnerships

• 13 Global Precision Medicine Software Market Company Profile (Key Players)
  • 13.1 Market Share, Company Revenue, Products, M&A, Developments
  • 13.2 Syapse, Inc.
  • 13.3 2bprecise, LLC
  • 13.4 Fabric Genomics, Inc.
  • 13.5 Pieriandx, Inc.
  • 13.6 Foundation Medicine, Inc.
  • 13.7 Translational Software Inc.
  • 13.8 Sunquest Information Systems, Inc.
  • 13.9 Sophia Genetics Sa
  • 13.10 N-Of-One, Inc. (A Subsidiary of Qiagen N.V.)
  • 13.11 Human Longevity, Inc.
  • 13.12 Company 11 & more

• 14 Global Precision Medicine Software Market - Appendix
  • 14.1 Sources
  • 14.2 Abbreviations